Skip to main content
$0.31 $0.00 (1.0%)

04:00 PM EDT on 09/29/23

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)

CAPS Rating: No stars

Current Price $0.31 Mkt Cap $13.5M
Open $0.31 P/E Ratio -0.14
Prev. Close $0.31 Div. (Yield) $0.00 (0.0%)
Daily Range $0.29 - $0.34 Volume 283,285
52-Wk Range $0.25 - $7.70 Avg. Daily Vol. 413,754

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

29 Outperform
2 Underperform
 

All-Star Players

3 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EIGR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Jimbyrnes1969 (< 20)
Submitted April 09, 2015

I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock… More

Jordrok (< 20)
Submitted January 02, 2015

No revenues... yet.

Fools bullish on NASDAQ:EIGR are also bullish on:

Fools bearish on NASDAQ:EIGR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EIGR.

Recs

0
Member Avatar oscillation (74.16) Submitted: 5/28/2015 9:24:56 AM : Outperform Start Price: $32.40 NASDAQ:EIGR Score: -200.34

nev

Recs

0
Member Avatar treasureoaks (< 20) Submitted: 4/22/2015 3:54:19 PM : Outperform Start Price: $203.85 NASDAQ:EIGR Score: -202.80

Oversold.

Recs

1
Member Avatar Jimbyrnes1969 (< 20) Submitted: 4/9/2015 1:25:22 PM : Outperform Start Price: $252.36 NASDAQ:EIGR Score: -205.14

I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.

Leaderboard

Find the members with the highest scoring picks in EIGR.

Score Leader

GreenAB

GreenAB (30.43) Score: +203.53

The Score Leader is the player with the highest score across all their picks in EIGR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
GreenAB 30.43 3/20/2015 Underperform NS $405.00 -99.92% +103.61% +203.53 0 Comment
IdahoInvestor 99.67 8/17/2015 Underperform 5Y $15.75 -97.97% +104.82% +202.79 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. OneBee < 20 5/4/2021 Outperform 3M $8.67 -96.31% +2.73% -99.04 0 Comment
foggs1 60.01 3/17/2021 Outperform 5Y $10.12 -96.84% +8.35% -105.19 0 Comment
odocoileus < 20 9/10/2020 Outperform 5Y $10.48 -96.95% +27.63% -124.57 0 Comment
drugtrader 51.09 7/8/2020 Outperform 5Y $9.43 -96.61% +36.64% -133.24 0 Comment
naughtyguy 97.20 8/21/2019 Outperform 5Y $10.56 -96.97% +46.32% -143.29 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. jeepdrew222 36.06 8/28/2018 Outperform 5Y $12.90 -97.52% +47.25% -144.77 0 Comment
BigDreamer 52.08 1/29/2018 Outperform 3Y $8.95 -96.42% +49.51% -145.93 0 Comment
skyrocket29 66.06 1/16/2018 Outperform 3M $9.10 -96.48% +52.81% -149.29 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EIGR.